Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-23-105925)

Filing Details

Accession Number:: 0001104659-23-105925
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-10-02 16:39:08
Reporting Period:: 2023-09-28

Accepted Time:: 2023-10-02 16:39:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1829635	Transcode Therapeutics Inc.	RNAZ	Pharmaceutical Preparations (2834)	811065054

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1854168	A Thomas Fitzgerald	C/O Transcode Therapeutics, Inc. 6 Liberty Square, #2382 Boston MA 02109	Chief Financial Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-09-28	49,350	$0.51	56,318	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents shares acquired pursuant to an underwritten public offering of common stock by the Issuer.
Reported amount reflects a 1-for-20 reverse stock split of the Issuer's common stock, which became effective as of May 22, 2023.